|
Re: FDA meeting
|
8
|
Resverlogix Corp.
|
Aug 09, 2022 12:44PM
|
|
Re: FDA meeting
|
4
|
Resverlogix Corp.
|
Aug 09, 2022 01:37PM
|
|
Re: Exposure in Motley Fool....
|
8
|
Resverlogix Corp.
|
Oct 08, 2019 01:32PM
|
|
Re: Exposure in Motley Fool....
|
3
|
Resverlogix Corp.
|
Oct 08, 2019 03:02PM
|
|
Re: Exposure in Motley Fool....
|
7
|
Resverlogix Corp.
|
Oct 08, 2019 07:17PM
|
|
Re: Exposure in Motley Fool....
|
2
|
Resverlogix Corp.
|
Oct 08, 2019 08:52PM
|
|
Re: Expected Results
|
4
|
Resverlogix Corp.
|
Jan 22, 2022 12:27PM
|
|
Re: Existing Security Holder Prospectus Exemption
|
2
|
Resverlogix Corp.
|
Dec 14, 2020 12:59PM
|
|
Re: Existing Security Holder Prospectus Exemption
|
3
|
Resverlogix Corp.
|
Dec 14, 2020 04:09PM
|
|
Re: Exercise of options Norma Biln
|
4
|
Resverlogix Corp.
|
Jul 29, 2020 01:29PM
|
|
Re: Exercise of options Norma Biln
|
3
|
Resverlogix Corp.
|
Jul 29, 2020 03:29PM
|
|
Re: Exempt Distribution
|
3
|
Zenith Epigenetics
|
Mar 16, 2020 08:08PM
|
|
Re: Exempt Distribution
|
4
|
Zenith Epigenetics
|
Mar 17, 2020 12:11PM
|
|
Re: Eversana.
|
6
|
Resverlogix Corp.
|
Jun 04, 2021 12:33AM
|
|
Re: Estimated Glomerular Filtration Rate
|
3
|
Resverlogix Corp.
|
Nov 17, 2019 06:02PM
|
|
Re: Est. Cash Position
|
5
|
Zenith Epigenetics
|
Apr 26, 2021 07:14PM
|
|
Re: Epigenetics and Coronavirus
|
7
|
Resverlogix Corp.
|
Mar 23, 2020 11:26AM
|
|
Re: Epigenetics and Coronavirus
|
2
|
Resverlogix Corp.
|
Mar 23, 2020 11:27AM
|
|
Re: End of the day “super hit down’ in a heartbeat
|
4
|
Resverlogix Corp.
|
Apr 05, 2019 05:12PM
|
|
Re: eGFR.....
|
7
|
Resverlogix Corp.
|
Feb 08, 2020 12:02PM
|
